ProShares Ultra Nasdaq Biotechnology (BIB) Holdings → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free BIB Stock Alerts $49.66 +0.72 (+1.47%) (As of 04/26/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Top 50 BIB HoldingsRankCompanyCurrent PriceWeightShares Held1NASDAQ BIO INDEX SWAP BNPN/A42.28%8,1242NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A37.42%7,1903NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A17.35%3,3344NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A12.62%2,4245NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALN/A6.88%1,3216AMGNAmgen$269.98+0.2%6.33%18,785 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 7VRTXVertex Pharmaceuticals$397.48-0.1%6.17%12,2268REGNRegeneron Pharmaceuticals$883.20-0.8%6.11%5,3269GILDGilead Sciences$65.42+0.2%6.06%71,34310NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A5.42%1,04211NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLCN/A3.55%68312AZNAstraZeneca$75.17+0.2%3.35%38,23713MRNAModerna$107.97+1.7%3.28%25,09114BIIBBiogen$208.90+3.2%2.33%9,54515ILMNIllumina$122.28+1.0%1.56%10,43316ALNYAlnylam Pharmaceuticals$143.31-0.3%1.54%8,27217BMRNBioMarin Pharmaceutical$80.91-1.5%1.43%12,38718NBIXNeurocrine Biosciences$135.99-1.3%1.11%6,53719VTRSViatris$11.57+0.9%1.11%77,98020RPRXRoyalty Pharma$28.00-0.4%1.05%29,33421SNYSanofi$49.13-0.5%1.05%17,98822INCYIncyte$51.68+1.0%1.00%14,74623MEDPMedpace$395.93+1.6%0.97%2,02124ARGXargenx$372.80+1.1%0.94%2,04325UTHRUnited Therapeutics$233.85-0.9%0.94%3,09226SRPTSarepta Therapeutics$128.77+1.1%0.92%6,16427BNTXBioNTech$87.21+0.6%0.70%6,35628ROIVRoivant Sciences$11.03+1.4%0.70%52,91629ASNDAscendis Pharma A/S$135.90-0.8%0.68%3,77330ITCIIntra-Cellular Therapies$73.26+1.6%0.59%6,36031CYTKCytokinetics$65.34+0.8%0.58%6,76132EXELExelixis$23.70+0.7%0.57%19,91133JAZZJazz Pharmaceuticals$109.46+1.9%0.57%4,09234PCVXVaxcyte$60.72+1.1%0.55%7,11635IONSIonis Pharmaceuticals$41.59-0.6%0.50%9,57436RVMDRevolution Medicines$35.96+1.8%0.50%10,81737APLSApellis Pharmaceuticals$49.86+4.0%0.48%7,92138BGNEBeiGene$153.58+3.4%0.46%2,71939BPMCBlueprint Medicines$93.00+2.5%0.46%4,02240HALOHalozyme Therapeutics$38.57+0.3%0.40%8,326These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy41KRYSKrystal Biotech$156.88+0.8%0.39%1,85642CRSPCRISPR Therapeutics$53.91+0.3%0.38%5,27243BBIOBridgeBio Pharma$24.88+2.3%0.37%11,54544MDGLMadrigal Pharmaceuticals$193.33-0.5%0.37%1,30845ALPNAlpine Immune Sciences$64.56-0.1%0.36%4,30646IMVTImmunovant$27.17-2.1%0.35%9,54047ALKSAlkermes$24.68+1.0%0.33%10,97048LEGNLegend Biotech$45.30+2.0%0.32%5,23449INSMInsmed$24.80-0.5%0.31%9,74850NUVLNuvalent$66.86+1.2%0.31%3,852 Geographic ExposureUnited States89.0%Ireland1.0%Bermuda0.7%Canada0.6%Switzerland0.4%Netherlands0.2%Jersey0.1%Currency ExposureUSD99.7%Sector ExposureHealth Care61.2%Consumer Discretionary0.7%Energy0.2%Industry ExposureBiotechnology56.2%Health Care Equipment & Supplies2.2%Diversified Consumer Services1.2%Pharmaceuticals0.6%Distributors0.5%Renewable Energy0.2%SubIndustry ExposureBiotechnology54.0%Life Sciences Tools & Services3.0%Pharmaceuticals1.2%Renewable Energy Equipment0.2%Health Care Equipment0.1% Related Companies and Tools Related Companies: Principal Healthcare Innovators ETF Top Holdings Invesco Nasdaq Biotechnology ETF Top Holdings Invesco Dorsey Wright Healthcare Momentum ETF Top Holdings First Trust Nasdaq Pharmaceuticals ETF Top Holdings Horizon Kinetics Medical ETF Top Holdings JPMorgan Healthcare Leaders ETF Top Holdings ProShares UltraShort Nasdaq Biotechnology Top Holdings Invesco S&P SmallCap Health Care ETF Top Holdings VanEck Biotech ETF Top Holdings VanEck Pharmaceutical ETF Top Holdings This page (NASDAQ:BIB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressProtect Your Bank Account Before It’s Too LateWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
